openPR Logo
Press release

Agenda Released for USA Biosimilars Conference this November

06-19-2018 01:41 PM CET | Health & Medicine

Press release from: SMi Group

Biosimilars USA

Biosimilars USA

SMi Group Reports: The official agenda for the 5th annual Biosimilars USA conference, which is taking place on the 14thand 15th November 2018 in New Jersey, USA, has been released.

SMi is proud to present the return of the Biosimilars USA conference to New Jersey, USA on the 14thand 15th November 2018, for its 5th year running. This year’s event will explore the developments in biosimilar drug development by gathering a global audience of biosimilar experts and industry-thought leaders to discuss biosimilar manufacturing and commercialization considerations specific to the U.S.

At the two-day event, attendees will have the chance to hear from expert keynote speakers, as well as exclusive case study updates presented by top manufacturing and leading distributors of market-approved biosimilars, who will offer attendees a unique insight into the areas of manufacturing, commercialization, device design, uptake, switching, interchangeability, and regulations.

This year’s expert speaker line-up includes:
• Christina Yunis, Global Biosimilars Market Development Lead, Pfizer Essential Health
• Houng Kim, Head of Strategy and Operations Division, Celltrion Healthcare
• Hillel Cohen, Executive Director, Scientific Affairs, Sandoz
• Nigel Rulewski, Vice President, Head Biosimilar Center of Excellence, IQVIA
• Don Stewart, CEO, PlantForm Corp
• Arun Nataraj, Senior Director, Business Development & Corporate Strategy, Amneal Pharmaceuticals
• Plus many more…

Biosimilars USA will also offer attendees the opportunity to expand their knowledge of biosimilars even further by attending two half-day, interactive workshops on 13th November 2018, run by industry experts from ZS Associates, Alkermes, Inc. and Harpper & Scintoa. More information about the workshops and their respective leaders can be found on the event website.

2018 Event Highlights:
• Assess which biosimilars should be kept in your pipeline
• Discuss a switching literature review from Sandoz
• Explore your options if your biosimilar has a better formulation/administration than its originator
• Examine FDA guidance on biosimilars to expedite approvals and acceptance
• Learn how to meet high GMP compliance when manufacturing outside of the U.S.
• Thoroughly assess partners biosimilar programs for in licensing
• Discover alternative expression systems for production of biosimilars and biobetters

The latest conference brochure is now available to download on the event website, where you can also register online: www.biosimilars-usa.com/PR1

Interested in sponsoring, exhibiting or speaking at this event?
Contact Alia Malick, Director, on +44 (0) 20 827 6168 or email amalick@smi-online.co.uk

For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6000 or ssapal@smi-online.co.uk

Biosimilars USA
14th – 15th November 2018
Renaissance Woodbridge Hotel, 515 US Highway 1 South, Iselin, New Jersey, USA

Follow us @SMiPharm
#SMiBioSimUSA

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network.

SMi Group
1 Westminster Bridge Road
London
SE1 7XW

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Agenda Released for USA Biosimilars Conference this November here

News-ID: 1088413 • Views:

More Releases from SMi Group

Darren Green, GSK, conference chair invitation to attend 3rd Annual AI in Drug Discovery Conference
Darren Green, GSK, conference chair invitation to attend 3rd Annual AI in Drug D …
SMi Reports: Conference Chairman Darren Green from GSK personally invites you the 3rd Annual AI in Drug Discovery Conference taking place on 14th and 15th March 2022 in London, UK. The conference will have a focus on case studies from leading pharma and biotech firms, as well as a exploring the latest innovations in machine learning for enhancing discovery pipelines. Darren Green, Director of Computational Chemistry at GSK will be chairing at
Registration is open for SMi’s 5th Annual Pharmaceutical Microbiology East Coast 2022
Registration is open for SMi’s 5th Annual Pharmaceutical Microbiology East Coa …
SMi Group reports: The 5th Annual Pharmaceutical Microbiology East Coast Conference is set to return in April 2022 with a key focus existing methods and novel tools in microbial control to assure continuity in product quality and patient safety. SMi Group is delighted to announce the 5th Annual Pharmaceutical Microbiology East Coast Conference, taking place on the 27th and 28th April 2022 in Boston, USA. The 2022 Conference theme is
SMi’s 10th Annual Pharmaceutical Microbiology UK Conference - A Virtual Conference with Online Access Only
SMi’s 10th Annual Pharmaceutical Microbiology UK Conference - A Virtual Confer …
SMi Reports: SMi Group have made the decision to open the microbiology conference and workshops to all microbiologists by transforming it into a virtual-remote online access event only on 17th and 18th January 2022. SMi’s 10th Annual Pharmaceutical Microbiology UK Conference will no longer take place in London, UK. Instead, the conference is taking place on 17 and 18 January 2022 and will open its doors to a global audience delivering
Co-chairs Philip Hewitt and Stefan Pryzyborski, invitation to join SMi’s 5th Annual 3D Cell Culture Conference
Co-chairs Philip Hewitt and Stefan Pryzyborski, invitation to join SMi’s 5th A …
SMi Group reports: Co-Chairs, Philip Hewitt and Stefan Pryzyborski for SMi’s 5th Annual 3D Cell Culture invite industry professionals to join the conference in February 2022. Philip Hewitt, Global Head of Early Investigative Toxicology, Merck and Stefan Przyborski, Professor in Cell Technology, Durham University invite industry professionals by releasing invite letter to join SMi’s 5th Annual 3D Cell Culture Conference 2022. This event will convene on February 9th – 10th 2022,

All 5 Releases


More Releases for USA

Thermocouple Probe Market 2020: Top Key Players Are OMEGA (USA), Fluke (USA), Th …
Thermocouple Probe Market Overview: Research report on The Thermocouple Probe Market by ‘Market Growth Insight’ covers deep analysis on key factors that directly influence the market growth including impact of COVID-19. The report is a thorough study of drivers, opportunities, restraints, challenges, and risks associated with the Thermocouple Probe market to help the players plan their growth activities and strategies carefully, while considering these crucial factors. The Thermocouple Probe report also
Risk Analysis Management Market 2019: By FireMon (USA), ForcePoint (USA), HPE De …
This report studies the Risk Analysis Management market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Risk Analysis Management market by product type and applications/end industries. The global Risk Analysis Management market is valued at xx million USD in 2017 and is expected to reach xx million USD by
Global Medical Wearable Market to 2025| Abbott Laboratories(USA), MC10(USA), Med …
Researchmoz added Most up-to-date research on "Global Medical Wearable Market Insights, Forecast to 2025" to its huge collection of research reports. The global Medical Wearable market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The objectives of this study are to define, segment, and project the size of the Medical Wearable market based on company,
Global Wearables in Healthcare Market to 2025: Abbott Laboratories(USA), MC10(US …
Researchmoz added Most up-to-date research on "Global Wearables in Healthcare Market Insights, Forecast to 2025" to its huge collection of research reports. The global Wearables in Healthcare market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The objectives of this study are to define, segment, and project the size of the Wearables in Healthcare
Risk Analysis Management Market Outlook to 2023 – FireMon (USA), ForcePoint (U …
Risk and Vulnerability Analysis – including the ability to create virtual network maps and visualize network connections and analyze traffic flow In this report, Publisher studies the present scenario (with the base year being 2017) and the growth prospects of global Risk Analysis Management market for 2018-2023. Request for Sample of Global Risk Analysis Management Market 2018 Research Report: https://www.researchreportsinc.com/sample-request?id=232759 Over the next five years, Publisher projects that Risk Analysis Management will
Risk Analysis Management Market Outlook to 2023 – FireMon (USA), ForcePoint (U …
In this report, Publisher studies the present scenario (with the base year being 2017) and the growth prospects of global Risk Analysis Management market for 2018-2023. Risk and Vulnerability Analysis – including the ability to create virtual network maps and visualize network connections and analyze traffic flow Request for Sample of Global Risk Analysis Management Market 2018 Research Report: https://www.researchreportsinc.com/sample-request?id=232759 Over the next five years, Publisher projects that Risk Analysis Management will